CORZ Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
164.2M
+42.5%
115.2M
+44.5%
79.8M
-1.7%
81.1M
+3.1%
78.6M
Cost of Revenue
94.2M
+10.6%
85.1M
+44.3%
59.0M
-23.6%
77.2M
+4.9%
73.6M
Gross Profit
70.0M
+132.7%
30.1M
+45.1%
20.8M
+431.5%
3.9M
-22.3%
5.0M
Operating Expenses
127.7M
-61.0%
327.4M
+203.6%
107.8M
+27.7%
84.4M
+211.1%
27.1M
R&D
0
0
0
0
0
SG&A
76.4M
+70.4%
44.8M
+485.7%
-11627000
-116.8%
69.4M
+21.8%
56.9M
Operating Income
-57700000
+80.6%
-297284000
-241.4%
-87067000
-8.1%
-80524000
-264.1%
-22118000
EBITDA
-254000
+98.1%
-13648000
+75.9%
-56745000
-4.1%
-54524000
-1521.8%
-3362000
Net Income
-1155310000
-232.8%
-347188000
-260.8%
216.0M
+249.9%
-144027000
+84.6%
-936799000
EPS (Basic)
$-3.32
-213.2%
$-1.06
-279.7%
$0.59
+231.1%
$-0.45
-1025.0%
$-0.04
EPS (Diluted)
$-3.32
-213.2%
$-1.06
-251.4%
$0.70
+255.6%
$-0.45
-1025.0%
$-0.04
Shares (Diluted)
325.3M
+0.7%
322.9M
+18.5%
272.4M
-14.5%
318.6M
+0.2%
318.0M
Core Scientific (CORZ) โ€” Financials